Viridian Therapeutics Bolsa (NASDAQ: VRDN)

Últimas noticias sobre Viridian Therapeutics (NASDAQ:VRDN) Bolsa

VIRIDIAN THERAPEUTICS INC

Viridian Therapeutics

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics Inc

CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) and Applied Digital Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) and trending on Wednesday and seeing increased investor attention on social platforms. Here&#8217;s a look at <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45755892/coreweave-stock-hits-new-highs-whats-going-on">what&#8217;s going on</a>. 
What To Know: CoreWeave stock has hit new highs multiple times already this week in the wake of the company&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45721501/applied-digital-stock-surges-on-ai-data-center-deal-with-coreweave-what-you-need-to-know">data center deal</a> with Applied Digital. 
The Ai infrastructure companies signed two approximately 15-year lease agreements with in which Applied Digital will provide CoreWeave with 250 megawatts (MW) of critical IT load at its data center site in North Dakota.
CoreWeave also has an option to expand capacity by an additional 150 MW, bringing the total potential load to 400 MW. Applied Digital forecasted approximately $7 billion in revenue over the contract period.
Applied Digital shares soared 48.5% on Monday following the announcement. CoreWeave shares also saw continued buying which helped the stock break out to new highs on Tuesday. CoreWeave shares were up in Wednesday&#8217;s pre-market session before pulling back at the open. The stock is up more than 175% over the past month, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
After taking a breather on Tuesday, Applied Digital shares are now surging again on Wednesday with the stock up more than 20% at last check, trading at $12.39, which marks new 52-week highs for the stock. 
The first 100 MW data center is expected to be ready for service in the fourth quarter of 2025. A second 150 MW data center facility is currently under construction and is expected to be ready for service in mid-2026. A third optional 150 MW data center is in the planning stages and could be ready for service in 2027, according to Applied Digital. 
&#8220;We believe these leases solidify Applied Digital&#8217;s position as an emerging provider of infrastructure critical to the next generation of artificial intelligence and high-performance computing,&#8221; said Wes Cummins, chairman and CEO of Applied Digital.
"As demand for AI accelerates exponentially, we believe that we are uniquely positioned to deliver substantial returns while supporting the evolving and dynamic needs of these rapidly evolving sectors."
The AI infrastructure space has been hot in recent months as the rise of generative AI and large language models has created incredible demand for high-performance computing. Many big chip players continue to <a href="https://www.benzinga.com/news/earnings/25/05/45657660/nvidia-q1-highlights-china-export-ban-hits-results-but-jensen-huang-says-demand-incredibly-strong">post strong growth</a>, driven by surging data center demand.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45767936/tech-bull-says-nvda-can-be-a-250-stock-if-trump-takes-a-step-back-from-tariffs">Tech Bull Says NVDA Can Be A $250 Stock If Trump Takes A Step Back From Tariffs</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/06/45765856/super-micro-rockets-up-206-spots-to-become-the-fastest-climber-on-the-fortune-500-list-smci-stock-up-over-43-this-year">Super Micro Rockets Up 206 Spots To Become The Fastest Climber On The Fortune 500 List: SMCI Stock Up Over 43% This Year</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock.

News

Movers

APLD

CRWV

CoreWeave, Applied Digital Shares Are Trending Wednesday: What's Going On?

Regeneron Pharmaceuticals (REGN) has been in a persistent downtrend for over 280 days. The stock is currently in the 10th Phase of its 18-Phase Adhishthana Cycle, our proprietary cyclical framework. Let's break down why this fall isn't just technical noise and what the Adhishthana Principles reveal about what lies ahead.
<h3 class="wp-block-heading">A Look Back at Regeneron's Adhishthana Cycle so far</h3>
Regeneron's current cycle began on January 29, 2018, and for much of it, the stock moved in line with Adhishthana&#8217;s expectations. The early phases were textbook examples of how market behavior follows cyclical energy, until everything changed in Phase 9.
<h4 class="wp-block-heading">Phase 2: The Rally of Buddhi</h4>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="924" height="664" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102631/Regeneron-Adhishthana-Phase-2.png" alt="Fig.1 Regeneron Phase 2 (Source: Adhishthana.com)" class="wp-image-13854" style="width:513px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102631/Regeneron-Adhishthana-Phase-2.png 924w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102631/Regeneron-Adhishthana-Phase-2-300x216.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102631/Regeneron-Adhishthana-Phase-2-768x552.png 768w" sizes="(max-width: 924px) 100vw, 924px" /><figcaption class="wp-element-caption">Fig.1 Regeneron Phase 2 (Source: Adhishthana.com)</figcaption></figure>
During Phase 2, Regeneron consolidated tightly for exactly 37 bars, just as the Adhishthana framework anticipates. What followed was a strong Rally of Buddhi, with the stock surging approximately 113%.
<h4 class="wp-block-heading">Phase 3: The Yajya Formation</h4>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="640" height="530" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102730/Regeneron-Phase-3-Adhishthana.png" alt="Fig.2 Regeneron Phase 3 (Source: Adhishthana.com)" class="wp-image-13855" style="width:367px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102730/Regeneron-Phase-3-Adhishthana.png 640w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04102730/Regeneron-Phase-3-Adhishthana-300x248.png 300w" sizes="(max-width: 640px) 100vw, 640px" /><figcaption class="wp-element-caption">Fig.2 Regeneron Phase 3 (Source: Adhishthana.com)</figcaption></figure>
Phase 3 delivered a textbook Yajya, a slight rally followed by a rounded top and then a sharp decline. Regeneron dropped ~33%, perfectly aligning with expectations for this phase.
<h4 class="wp-block-heading">Phase 6: Discovery of the Nirvana Level</h4>
In Phase 6, Regeneron established its Nirvana Level at $671.41. This level now acts as a valuation magnet, drawing prices toward it during selling phases and serving as a benchmark throughout the remainder of the cycle.
<h3 class="wp-block-heading">The Turning Point: What Went Wrong in Regeneron&#8217;s Phase 9?</h3>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="370" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04103103/Regeneron-Cakra-Adhishthana.png" alt="Fig.3 Regeneron Phase 9 and Cakra (Source: Adhishthana.com)" class="wp-image-13856" style="width:902px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04103103/Regeneron-Cakra-Adhishthana.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04103103/Regeneron-Cakra-Adhishthana-300x93.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04103103/Regeneron-Cakra-Adhishthana-1024x316.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/04103103/Regeneron-Cakra-Adhishthana-768x237.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.3 Regeneron Phase 9 and Cakra (Source: Adhishthana.com)</figcaption></figure>
Typically, Phase 9 marks the supreme move, a breakout above the bullish &#8220;Cakra&#8221; consolidation channel that forms between Phases 4 to 8. This move often launches the stock into the Himalayan Ascent.
However, when a stock breaks the Cakra on the downside, it doesn't rise; it plunges.
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">"When the underlying breaks the Cākra on the flip side, it typically draws consolidation up to the Guna triads. The movement after the break is typically highly significant, and the selling momentum is extremely strong. Such a move shall be called the Move of Pralayā." — Adhishthana: The Principles That Govern Wealth, Time &amp; Tragedy
</blockquote>
Regeneron did exactly that, it broke the Cakra on the flip side, triggering what I call the Move of Pralaya, a collapse of bullish structure and sentiment. Since that break, the stock has fallen by ~54%.
<h3 class="wp-block-heading">What's Next for Regeneron?</h3>
Now in Phase 10, Regeneron is stuck in structural limbo. According to Adhishthana Principles, no meaningful recovery can occur until it enters the Guna Triads, i.e, Phases 14, 15, and 16. This triad begins on February 7, 2028. Only after the completion of the triads can we assess whether the stock will rebuild momentum and attempt to reach its Nirvana, the ultimate price peak across the 18-phase cycle.
Until then, the structure suggests continued weakness and uncertainty.
<h3 class="wp-block-heading">Investor Takeaway</h3>
Regeneron's fall is not random, it's deeply rooted in a structural breakdown identified by the Adhishthana framework. The breach of the Cakra has invited the Move of Pralaya, and data shows that recovery before the Guna Triads is unlikely. Investors should avoid fresh positions at this stage. For existing holders, reevaluation is warranted, as the road to recovery may still be years away.&nbsp;

Equities

Technicals

Opinion

Signals

Trading Ideas

REGN

Why Regeneron Is Falling And Why You Should Avoid It

Former White House chief strategist Steve Bannon had high praise for both President Donald Trump and Treasury Secretary Scott Bessent during his <a href="https://www.youtube.com/watch?v=dHI2Vn0hPa0">appearance</a> at the Semafor World Economy Summit in April, calling Trump a "very sophisticated businessman" and describing Bessent as a "safe pair of hands."&nbsp;
The comments come amid growing scrutiny over Elon Musk's attempts to overhaul the federal government through the Department of Government Efficiency.
<h2 class="wp-block-heading">Praise For Bessent And Trump, Criticism For Musk</h2>
"Scott is a safe pair of hands that understands capital markets deeply," Bannon said. "He's done this for 30 years. He has a very strong sense of what markets need to hear. I may not like it, but he's telling me the truth—that's Scott Bessent."
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
Bannon, who hosts &#8220;Bannon&#8217;s War Room&#8221; podcast and remains a MAGA movement influencer, backed Bessent during a high-profile clash with Musk over control of the Internal Revenue Service commissioner appointment. The power struggle ended with Bessent's preferred candidate replacing Musk's pick after only three days. "If [Commerce Secretary] Howard Lutnick had been, it'd have been an unmitigated disaster," Bannon said.
As for Trump, Bannon reiterated his confidence in the president's strategic instincts. "President Trump is a very sophisticated businessman," he said, countering critics who questioned Trump's embrace of economic populism and new tariff strategies.
<h2 class="wp-block-heading">Musk's Missteps Underscore Bannon's Point</h2>
Musk&#8217;s time in government <a href="https://www.benzinga.com/25/05/45667224/dan-ives-calls-elon-musks-trump-white-house-exit-music-to-tesla-shareholders-ears-predicts-renewed-autonomous-vehicle-focus">seems to be over now</a>, but it started with ambitious promises—cutting $2 trillion in spending and slashing bureaucracy—but ended in chaos and backlash. His attempts to move fast and break things clashed with Washington's entrenched norms and legal limits.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
Bannon believes Musk failed to grasp the scale and complexity of the federal government. "You have to go to the Pentagon," Bannon said at the summit, arguing that real waste and abuse can't be tackled without understanding defense spending. He questioned Musk's failure to produce transparent accounting for DOGE's claimed budget cuts. "None of this makes sense," he added. "We need to know exactly what he found as far as fraud goes."
Bannon's criticism of Musk didn't stop at budget cuts or federal dysfunction. In an interview with <a href="https://www.businessinsider.com/steve-bannon-prison-more-powerful-musk-trump-maga-third-term-2025-4">Business Insider</a> in April, Bannon <a href="https://www.benzinga.com/general/biotech/25/04/44891849/steve-bannon-says-elon-musk-is-evil-blasts-his-brain-chip-ambitions-as-technofeudalist-plot-to-hijack-humanitys-future">took aim at Musk's Neuralink project</a>, calling it "satanism with a brain chip."
"Elon was always evil. He&#8217;s a techno-feudalist. We are on the side of the human being,&#8221; Bannon told Business Insider, accusing Musk of pushing a "techno-feudalist" agenda designed to hijack the future of humankind.
Bannon&#8217;s remarks reflect a deeper ideological and personal feud between the two men, both vying for influence in Trump's orbit. While Musk has tried to reshape government with disruptive tech-centric policies, Bannon has positioned himself as a defender of traditional, human-centered governance.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Steve Bannon Says 'President Trump Is A Very Sophisticated Businessman,' Calls Scott Bessent 'Safe Pair Of Hands'

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.17% to 42,591.06 while the NASDAQ rose 0.34% to 19,465.31. The S&amp;P 500 also rose, gaining, 0.27% to 5,986.07.
Check This Out: <a href="https://www.benzinga.com/markets/large-cap/25/06/45744658/jim-cramer-recommends-nvidia-over-very-cheap-semiconductor-stock">Jim Cramer Recommends Nvidia Over &#8216;Very Cheap&#8217; Semiconductor Stock</a>
Leading and Lagging Sectors Communication services shares jumped by 1% on Wednesday.
In trading on Wednesday, utilities stocks fell by 0.6%.
Top Headline
Shares of Dollar Tree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) fell more than 10% on Wednesday after its first-quarter 2025 earnings report.
Net sales increased 11.3% to $4.6 billion, beating the consensus of $4.53 billion and the management guidance of $4.5 billion—$4.6 billion.
Same-store net sales increased 5.4%, driven by a 2.5% increase in traffic and a 2.8% increase in average ticket, beating the management guidance growth of 3% – 5%. Dollar Tree reported adjusted earnings of $1.26 per share, beating the analyst estimate of $1.21, better than management expectation of $1.10 – $1.25.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares shot up 191% to $15.69.</li>
<li>Shares of K Wave Media Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWM#NASDAQ">KWM</a>) got a boost, surging 124% to $4.3046 after the company announced it signed a $500 million securities purchase agreement to advance a bitcoin-focused treasury strategy.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) shares were also up, gaining 100% to $0.5581 after the company announced it was granted FDA Breakthrough Therapy Designation status for Iopofosine I-131.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>PTL Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLE#NASDAQ">PTLE</a>) shares dropped 41% to $0.4300.</li>
<li>Shares of Raytech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) were down 27% to $1.1906.</li>
<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) was down, falling 23% to $5.19. ReShape Lifesciences recently announced its Quality Management System and entire commercial portfolio of medical devices sold in Europe and in the UK have been certified under the European Union Medical Device Regulation 2017/745 and UK Conformity Assessment.</li>
</ul>
Commodities In commodity news, oil traded down 0.2% to $63.26 while gold traded up 0.8% at $3,402.30.
Silver traded up 0.1% to $34.665 on Wednesday, while copper rose 1.1% to $4.8865.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.5%, while Spain's IBEX 35 Index fell 0.2%. London's FTSE 100 rose 0.3%, Germany's DAX 40 gained 0.6% and France's CAC 40 rose 0.7% during the session.
Asia Pacific Markets
Asian markets closed higher on Wednesday, with Japan's Nikkei gaining 0.80%, Hong Kong's Hang Seng Index jumping 0.60%, China's Shanghai Composite gaining 0.42% and India's BSE Sensex gaining 0.32%.
Economics
<ul class="wp-block-list">
<li>The EIA said crude oil inventories in the U.S. declined by 4.304 million barrels in the week ended May 30, compared to market estimates of a 0.9 million barrel fall.</li>
<li>The ISM services PMI dipped to 49.9 in May versus 51.6 in the previous month and also missing market estimates of 52.</li>
<li>The S&amp;P Global composite PMI was revised higher to 53.0 in May compared to a preliminary reading of 52.1 and versus April's reading of 50.6.</li>
<li>U.S. private business added 37K workers to their payrolls during May versus a revised 60K gain in the previous month.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/downgrades/25/06/45771113/this-apple-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday-2">This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Eurozone

Commodities

Intraday Update

Markets

CLRB

DLTR

MULN

PTLE

RSLS

US Stocks Higher; Dollar Tree Shares Plunge After Q1 Earnings

<a href="https://www.bloomberg.com/news/articles/2025-06-04/trump-bill-unlikely-to-repeal-estate-tax-senate-leader-says?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-04/trump-bill-unlikely-to-repeal-estate-tax-senate-leader-says?embedded-checkout=true</a>

General

'Trump Bill Unlikely to Repeal Estate Tax, Senate Leader Says'- Bloomberg

Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) has outperformed the market over the past 20 years by 2.36% on an annualized basis producing an average annual return of 10.69%. Currently, Yum Brands has a market capitalization of $39.98 billion. 
Buying $1000 In YUM: If an investor had bought $1000 of YUM stock 20 years ago, it would be worth $7,550.25 today based on a price of $143.84 for YUM at the time of writing.
<h3>Yum Brands's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749050112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

JP Morgan analyst Matthew Boss maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Neutral and raises the price target from $88 to $95.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Dollar General, Raises Price Target to $95

GlobalFoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) <a href="https://www.benzinga.com/pressreleases/25/06/g45768528/globalfoundries-announces-16b-u-s-investment-to-reshore-essential-chip-manufacturing-and-accelerat" target="_blank" rel="noreferrer noopener">plans to inject $16 billion</a> into expanding its semiconductor manufacturing and packaging operations across New York and Vermont facilities.
What Happened: The company announced on Wednesday that it aims to boost domestic chipmaking. 
The funding includes $13 billion for facility expansion and $3 billion for R&amp;D. The focus is on silicon photonics, GaN power technologies, and advanced packaging.
The announcement comes after the launch of the New York Advanced Packaging and Photonics Center—the first U.S.-based facility dedicated to silicon photonics packaging.
Also Read: <a href="https://www.benzinga.com/markets/large-cap/25/06/45748492/taiwan-semiconductors-japan-chip-factory-faces-delays-while-us-expansion-takes-priority" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor&#8217;s Japan Chip Factory Faces Delays, While U.S. Expansion Takes Priority</a>
Why It Matters: CEO Tim Breen said the AI boom is fueling demand for GF&#8217;s technologies. The company makes a proprietary FDX platform and silicon photonics solutions.
GlobalFoundries aims to support next-gen data centers and edge devices with energy-efficient, high-performance chips built in America.
Commerce Secretary Howard Lutnick said the move exemplifies America&#8217;s latest reshoring efforts under the Trump administration.
Industry leaders, including Apple Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Tim Cook, SpaceX&#8216;s Gwynne Shotwell, Advanced Micro Devices Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) Lisa Su, and Qualcomm&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) Cristiano Amon, voiced support, citing the importance of a reliable U.S. semiconductor supply chain.
Related ETFs: iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) and VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>).
Price Action: GFS shares are trading higher by 1.50% at $37.42 on the last check on Wednesday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45769527/trump-threatened-tariffs-on-apple-and-mattel-why-the-barbie-maker-could-slide-free-but-tim-cooks-company-might-not" target="_blank" rel="noreferrer noopener">Trump Threatened Tariffs On Apple And Mattel—Why The Barbie Maker Could Slide Free, But Tim Cook&#8217;s Company Might Not</a></li>
</ul>
Image: Shutterstock

Tech

AAPL

INTC

QCOM

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

GlobalFoundries Commits $16 Billion To US Chip Expansion As AI Drives Demand

JP Morgan analyst Doug Anmuth maintains Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Overweight and raises the price target from $5360 to $6000.

BKNG

JP Morgan Maintains Overweight on Booking Holdings, Raises Price Target to $6000

Wall Street tech guru <a href="https://www.benzinga.com/topic/dan-ives">Dan Ives</a> is making an entrance into the <a href="https://www.benzinga.com/etfs">ETF space</a> with a bang and his own ticker. One of Wall Street&#8217;s best-known tech analysts, famous for his brash predictions on Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Ives is now making his market calls tradable with the Dan Ives Wedbush AI Revolution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVES#NYSE">IVES</a>), reported Bloomberg.
The ETF, which debuted Wednesday, looks to catch the current boom in AI. It&#8217;s centered around Ives&#8217; &#8220;proprietary research&#8221; and holds 30 of his favorite companies with connections to artificial intelligence. Think semiconductors, cybersecurity companies, robotics, and so on—essentially, the kinds of stocks Ives has been pounding the table about for years.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45771855/vistashares-unleashes-wild-a-2x-leveraged-etf-powered-by-animal-spirits-and-market-momentum">VistaShares Unleashes WILD, A 2x Leveraged ETF Powered By Animal Spirits And Market Momentum</a> Ives believes AI will be the biggest tech theme in 50 years. He believes Wedbush has been early in tracking the AI revolution and has identified the winners. Ives has become a go-to name for retail investors hunting for tech insights on social and digital media. Now, fans of his market views can literally invest in them, no decoder ring required. The IVES ETF is the latest addition to a growing trend of finance personalities establishing funds constructed around their names. Fundstrat&#8217;s Tom Lee and economist Nouriel Roubini recently introduced ETFs, and even Donald Trump&#8217;s media entity is considering its own set of funds. Lee's ETF, in particular, Fundstrat Granny Shots US Large Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRNY#NYSE">GRNY</a>) has already notched more than $1 billion in inflows since debuting in late 2024, noted Bloomberg 
But the ETF universe is crowded. The American market is chock-full of more than 4,200 ETFs, and AI funds are reproducing quicker than ChatGPT requests. Some have succeeded, and many have not, so the stakes are high.
Nevertheless, Wedbush is wagering big on Ives&#8217; name value and analysis. 
This new ETF can be worth watching for individual investors seeking a one-click means of playing the AI megatrend and who have confidence in Ives&#8217; instincts. 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/06/45756325/why-victorias-secrets-breach-is-a-wake-up-call-for-cybersecurity-etf-investors">Why Victoria&#8217;s Secret&#8217;s Breach Is A Wake-Up Call For Cybersecurity ETF Investors</a></li>
</ul>
Photo: Shutterstock
 
<figure class="wp-block-image"><img decoding="async" src="https://www.humanizeai.pro/_next/static/media/likeDislike.e10cc698.svg" alt="like" /></figure>

New ETFs

ETFs

GRNY

IVES

TSLA

Wedbush Launches AI Revolution ETF Backed By Dan Ives' Proprietary Tech Picks

Shares of CrowdStrike Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) were trading lower on Wednesday after the company reported disappointing <a href="https://www.benzinga.com/markets/earnings/25/06/45758937/crowdstrike-q1-earnings-revenue-eps-miss-estimates-cybersecurity-company-raises-fy26-guidance-approves-1b-buyback">quarterly results on Tuesday.</a>
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
BofA Securities On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58b96e16b85e930001592a0f/tal-liani">Analyst Tal Liani</a> downgraded the rating from Buy to Neutral, while raising the price target from $420 to $470.
CrowdStrike's underlying trends remained healthy in the fiscal first quarter, Liani said in the downgrade note. ARR (annual recurring revenue) grew 22%, beating Street expectations by 100 basis points (bps), he added.
Next-Gen SIEM ARR tripled on a year-on-year basis, Cloud Security growth accelerated and Falcon Flex adoption grew by 31% sequentially, the analyst stated. "We favor CrowdStrike&#8217;s fundamentals and growth prospects, but believe the valuation leaves only limited upside from the current level," he further wrote.
Canaccord Genuity On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f7dc321a442ba0001da7ac1/kingsley-crane">Analyst Kingsley Crane</a> downgraded the rating from Buy to Hold, while raising the price target from $420 to $475.
CrowdStrike reported solid quarterly results, with ARR growing to $4.44 billion and net-new ARR coming in at $194 million, Crane said in his downgrade note. Management reaffirmed their full-year revenue guidance of $4.74 billion-$4.81 billion, he added.
The company also announced a new share buyback program worth $1 billion, "underscoring confidence in long-term growth and cash generation," the analyst wrote. Although CrowdStrike&#8217;s business operations since <a href="https://www.benzinga.com//node/39864144">the July 19, 2024 incident</a> is "nothing short of remarkable," the current stock valuation represents a balanced risk/reward, he further stated.
RBC Capital Markets On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">Analyst Matthew Hedberg</a> maintained an Outperform rating, while lifting the price target from $500 to $510.
Although CrowdStrike's fiscal first-quarter results were "slightly noisy," they represented a strong start to the year, Hedberg said in a note. NNARR (net new annual recurring revenue) stood at $193.8 million, representing a year-on-year decline of 8.5% but topping consensus of $176.7 million and coming in line with the four-year average, he added.
Management guided to sequential growth in NNARR doubling in the second quarter, which suggests a figure of $204.6 million, higher than the current consensus of $192.6 million, the analyst stated. "Profitability going higher and a new $1B share repurchase plan were positives while there was no update regarding the U.S. Fed investigation," he further wrote.
Truist Securities On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein">Analyst Joel Fishbein</a> reiterated a Buy rating, while raising the price target from $450 to $500.
CrowdStrike reported strong quarterly results, with its better-than-expected NNARR driven by "large deal activity, Falcon Flex, the MSSPs and platform adoption," Fishbein said.
The analyst added, however, that revenue of $1.1 billion came in line with the midpoint of guidance, "as the CCP program and a related partner program that were ended last quarter created an ~$11M headwind to subscription revenue." Non-GAAP operating margin of 18.2% significantly surpassed the high end of guidance, driven by platform efficiency, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> reaffirmed a Buy rating, while lifting the price target from $420 to $530.
CrowdStrike's NNARR declined by 14% sequentially, much better than the guidance of a 21%-23% decline, Cikos said. Management expects NNARR growth to &#8220;at least double&#8221; in the second quarter from the growth posted a year ago, which implies "baseline growth of 5.6%," he added.
They also expressed increased confidence in NNARR growth reaccelerating in the back half of fiscal 2026, the analyst stated. This confidence is "buoyed by traction with Flex, evidence of use outpacing contracted spend via re Flex customers, and Next-Gen SIEM maintaining triple-digit yr-yr growth," he further wrote.
Rosenblatt Securities On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585aa876b5a482000151d0ed/catharine-trebnick">Analyst Catharine Trebnick</a> maintained a Buy rating and price target of $515.
CrowdStrike's stock fell sharply after the company reported its latest revenue figure below the Street estimates, Trebnick said. She added, however, that Falcon Flex's adoption rate was "impressive," taking the total account value to more than $3.2 billion.
Management reiterated their initial revenue growth guidance of 21% for fiscal 2026, while expressing confidence in a re-acceleration in the second half of the year, the analyst stated. "We continue to believe in CrowdStrike&#8217;s capacity to execute its strategic growth initiatives, enhance profitability, and leverage the growing cybersecurity market," she further wrote.
JMP Securities On CrowdStrike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6298be750c34880001d668d9/trevor-walsh">Analyst Trevor Walsh</a> reiterated a Market Outperform rating and price target of $500.
CrowdStrike reported earnings of 73 cents per share, beating consensus of 67 cents per share, while revenues of $1.103.4 billion came in short of estimates of $1.105.3 billion, Walsh said. The company guided to non-GAAP earnings of 82-84 cents per share for the fiscal second quarter, higher than consensus of 81 cents per share, he added.
The full-year revenues and non-GAAP earnings guidance came in at $4.743-$4.805 billion and $3.44-$3.56 per share, respectively, the analyst stated.
CRWD Price Action: Shares of CrowdStrike Holdings had declined by 4% to $469.01 at the time of publication on Wednesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> CrowdStrike Stock Slips: Analyst Downgrades Before Earnings</a></li>
</ul>
Photo: Michael Vi / Shutterstock

Analyst Color

Downgrades

Reiteration

CRWD

CrowdStrike's Outlook, Buyback Plan Impress, But Some Analysts Say Valuation Limits Upside

JP Morgan analyst Pinjalim Bora maintains Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) with a Underweight and raises the price target from $13 to $14.

ASAN

JP Morgan Maintains Underweight on Asana, Raises Price Target to $14

JP Morgan analyst Doug Anmuth maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Overweight and raises the price target from $225 to $240.

AMZN

JP Morgan Maintains Overweight on Amazon.com, Raises Price Target to $240

<a href="https://blogs.nvidia.com/blog/blackwell-performance-mlperf-training/ " title="https://blogs.nvidia.com/blog/blackwell-performance-mlperf-training/ ">https://blogs.nvidia.com/blog/blackwell-performance-mlperf-training/&nbsp;</a>
&nbsp;

NVDA

'NVIDIA Blackwell Delivers Breakthrough Performance in Latest MLPerf Training Results' - Blog

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.TriCountiesBank.com&amp;esheet=54264848&amp;newsitemid=20250604822725&amp;lan=en-US&amp;anchor=Tri+Counties+Bank&amp;index=1&amp;md5=d4e8aa505a15f6ce04ff8e46e2b39001">Tri Counties Bank</a> has restructured its business and commercial management teams to provide more specialized expertise and superior service for California businesses. This move strengthens Tri Counties Bank's ability to better serve businesses of all sizes with streamlined access to specialized lending, helping businesses scale faster, navigate market fluctuations, and seize growth opportunities.
The restructuring ensures businesses receive tailored financial solutions at every stage of growth:
<ul>
<li>Business Banking, for businesses between $2 million and $10 million in revenue</li>
<li>Commercial Banking, for businesses between $10 million and $50 million in revenue</li>
<li>Middle Market and Specialty Banking, for businesses with annual revenues greater than $50 million</li>
</ul>
Scott Myers, Head of Wholesale Banking at Tri Counties Bank, led the strategic reorganization of the business banking divisions, bringing more than 25 years of experience to reshape how California businesses receive financial services.

TCBK

Tri Counties Bank Restructures Business And Commercial Management Teams To Provide Expert Service For California Businesses

<a href="https://www.bloomberg.com/news/articles/2025-06-04/lutnick-says-he-expects-tariff-analysis-on-aircraft-parts-soon?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-04/lutnick-says-he-expects-tariff-analysis-on-aircraft-parts-soon?embedded-checkout=true</a>

'Lutnick Says He Expects Tariff Analysis on Aircraft Parts Soon'- Bloomberg

Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) will release its quarterly earnings report on Thursday, 2025-06-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Rent the Runway to report an earnings per share (EPS) of $-8.35.
Anticipation surrounds Rent the Runway's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company missed EPS by $1.19, leading to a 7.71% drop in the share price the following trading session.
Here's a look at Rent the Runway's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-2.25</td>
<td>-4.45</td>
<td>-5.47</td>
<td>-7.43</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-3.44</td>
<td>-4.94</td>
<td>-4.17</td>
<td>-6.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>-5.0%</td>
<td>-28.000000000000004%</td>
<td>-13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1749049394_0.png" alt="eps graph" />
<h3>Market Performance of Rent the Runway's Stock</h3>
Shares of Rent the Runway were trading at $6.24 as of June 03. Over the last 52-week period, shares are down 76.37%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/RENT/earnings">To track all earnings releases for Rent the Runway visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RENT

A Look Ahead: Rent the Runway's Earnings Forecast

<ul>
<li>Collaboration delivers improved connectivity, reliability, and performance for NIO automotive solutions</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.keysight.com&amp;esheet=54264857&amp;newsitemid=20250604547502&amp;lan=en-US&amp;anchor=Keysight+Technologies%2C+Inc.&amp;index=1&amp;md5=9c842836e303aceccdb1f94aced61468">Keysight Technologies, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) has enabled NIO to successfully validate the wireless systems in its smart electric vehicles using Keysight network emulation solutions. As a result, NIO's vehicles now comply with 3GPP and IEEE 802.11 standards and deliver improved connectivity and performance to support the next generation of electric vehicle development.

KEYS

Keysight Technologies Enables NIO To Validate Wireless Systems In Smart Electric Vehicles Using Keysight Network Emulation Solutions

EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-06-05. Here's a quick overview of what investors should know before the release.
Analysts are estimating that EuroDry will report an earnings per share (EPS) of $-1.25.
The announcement from EuroDry is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.18, which was followed by a 3.2% increase in the share price the next day.
Here's a look at EuroDry's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.07</td>
<td>-0.23</td>
<td>0.54</td>
<td>-0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.25</td>
<td>-1.42</td>
<td>-0.17</td>
<td>-1.18</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1749049386_0.png" alt="eps graph" />
<h3>Market Performance of EuroDry's Stock</h3>
Shares of EuroDry were trading at $8.155 as of June 03. Over the last 52-week period, shares are down 62.33%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/EDRY/earnings">To track all earnings releases for EuroDry visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EDRY

Insights Ahead: EuroDry's Quarterly Earnings

Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) will release its quarterly earnings report on Thursday, 2025-06-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Torrid Holdings to report an earnings per share (EPS) of $0.14.
Anticipation surrounds Torrid Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.04, leading to a 3.98% increase in the share price the following trading session.
Here's a look at Torrid Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.07</td>
<td>0.03</td>
<td>0.08</td>
<td>0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.03</td>
<td>-0.01</td>
<td>0.08</td>
<td>0.12</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>-25.0%</td>
<td>-6.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1749049368_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Torrid Holdings were trading at $5.24 as of June 03. Over the last 52-week period, shares are down 21.77%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CURV/earnings">To track all earnings releases for Torrid Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CURV

Torrid Holdings's Earnings: A Preview

Press Releases

Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results

Viridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (TED)

Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)

Comments

Viridian Therapeutics

Noticias

Últimas noticias sobre Viridian Therapeutics (NASDAQ:VRDN) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL